ASHPOfficial

Join us for a special podcast series spotlighting student member experiences at 2024 Midyear Clinical Meeting & Exhibition in New Orleans, LA. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be - there is nothing like it! The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join us for a special podcast series spotlighting student member experiences at 2024 Midyear Clinical Meeting & Exhibition in New Orleans, LA. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be - there is nothing like it! The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

There’s Nothing Like It is the theme for the ASHP Midyear Clinical Meeting 2024 and there’s nothing like developing your clinical pharmacy leadership skills. Join experienced conference attendees and upcoming speakers presenting at the meeting to learn more about all Midyear has to offer! The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Antifungal therapeutic drug monitoring is a critical component of individualized, precision treatment for fungal infections and for antifungal stewardship. Antifungal therapeutic drug monitoring can help improve outcomes through minimizing toxicity associated with supratherapeutic drug levels and prevent treatment failure from subtherapeutic levels. Also, in vitro studies have shown that suboptimal drug levels can lead to antifungal resistance, supporting therapeutic drug monitoring's potential role in preventing the emergence of antifungal-resistant organisms. This episode podcast, we discuss outcome data when antifungal TDM is used, role of antifungal TDM with isavuconazole and echinocandins, TDM in outpatient settings, and other controversies. We will also highlight the recent antifungal TDM insights published by SIDP. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Besides remembering the counseling advice of not placing ear drops into eyes, there aren’t many ophthalmologic key points that pop into your mind. This podcast session will help open your eyes (pun intended) to commonly used eye therapies within the emergency department. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

According to the CDC, nearly 42% of Americans have obesity, with estimated medical costs of $173+ billion dollars annually. While medications to promote weight loss have become popular, it is equally important to also review current medications for those that may lend to weight gain. Optimizing these medications with weight neutral or weight negative alternatives can help patients achieve greater success in their weight loss efforts. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Emily Doycich sits down with VA pharmacists Susan Duquaine and Abbey Loy to discuss best practices for implementing a pharmacogenomics program withing a health system including clinical and operational considerations along with how they addressed barriers and keep up with this ever-evolving area of pharmacy practice. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join us as we dive into 'Race-Based Clinical Calculations Causing Healthcare Disparities,' an essential session from the Midyear Clinical Meeting and Exhibition. We'll explore the reasons this topic matters, actionable steps listeners can take to address these disparities, and the unique benefits of attending Midyear for professional growth. Don't miss out on this critical discussion shaping the future of equitable healthcare! The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The podcast will discuss optimizing the diagnosis, antimicrobial selection, and duration of therapy for adult patients with community-acquired pneumonia admitted to the hospital. This engaging conversation will bring the guidelines to life as an emergency medicine antimicrobial stewardship physician and an infectious diseases clinical pharmacist discuss navigating patients from hospital arrival through admission and how stewardship plays an immediate role in the patient care plan. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this first in a series, Christi Jen and Holly Geyer sit down with Libby Johnson to discuss the creation of an opioid stewardship program, including the identification of key stakeholders, guidelines to follow as well as initial goals for a newly founded opioid stewardship program. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Dr. Andrea Sikora and Dr. Brian Murray discuss the AJHP theme issue on critical care pharmacy practice with host and AJHP Editor in Chief Dr. Daniel Cobaugh. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join ASHP host Cindy Von Heeringen as she discusses the 2025 ASHP Pharmacy Forecast and associated Midyear session with Joe DiPiro (Forecast Editor), Rena Gosser (Advisory Committee member), and James Hoffman (Forecast Deputy Editor). The 2025 ASHP Pharmacy Forecast will be published in AJHP in December in conjunction with the Midyear session. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast is part of a series unpacking harmful PBM practices. The series will inform listeners about PBMs’ influence over nearly all aspects of patient care and the profession of pharmacy. The series will also identify key resources and strategies enabling pharmacy professionals to engage in effective advocacy efforts to achieve meaningful PBM reform. In this episode, we look at the rise of so-called “PBM Group Purchasing Organizations” – affiliated entities recently established by each of the major PBMs. Critics allege that PBM GPOs do not add value to the healthcare system and function solely to enable PBMs to collect excessive profits. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In celebration of Veterans Day 2024, @ASHP Official is highlighting three pharmacist members who volunteered to join the military in service to our Nation. In this episode, we speak with Peter Bulatao, Aaron Middlekauff, and Ryan Lampien about their stories, reflections, and perspectives on how their military experience helped shape their careers, lives, and their sense of paying it forward to provide an inspiration for others. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, we discuss the safety and efficacy of administering undiluted levetiracetam via IV push as well as the considerations for incorporating this practice into pharmacy and nursing workflows. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP’s Senior education director, Cindy von Heeringen is joined by Dr. Alex Infante, Clinical Assistant Professor at Texas A&M University and Dr. Jennie Jarrett, Director of Science and Drug Policy at the American Medical Association as they discuss their upcoming Midyear session that focuses on the ability of pharmacists to use available resources and strategies to positively impact patient care by overcoming barriers in the implementation and utilization of harm reduction services. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Emergency medicine organizations have declared that racism is a public health crisis. Our panelists will discuss treatment inequities identified within emergency and prehospital medicine, populations at risk of discrimination, and research opportunities to further describe our current state and future opportunities. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP welcomes Dr. Kate Cozart, Clinical Pharmacist Practitioner, Primary Care, PGY1 Residency Program Coordinator, U.S. Department of Veterans Affairs and Dr. Amy Henneman, Associate Professor of Pharmacy Practice, Belmont University College of Pharmacy and Health Sciences as they join Senior Education Director Cindy von Heeringen for a chat about their upcoming midyear session focused on professional identity formation as a strategy to prevent burnout for both pharmacists and technicians. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast will focus on how generative artificial intelligence (AI) impacts inpatient pharmacy practice. We will focus on current technologies and future applications of generative AI in this space. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast discusses the two models of infusion services to facilitate outpatient and home health care, and the care benefits and challenges associated with therapy. A patient care goal is to enhance the care experience and best streamline infusion therapy through a modality that is most efficient, while equally safe, and less disruptive to day-to-day activities. Health-systems have developed strategies for optimizing a balance between the use of home infusion and hospital outpatient infusion services to ensure optimal patient care and financial performance. Payers implement a variety of tools that enhance care affordability based on formulary status, site of care restrictions, and medication dispensing model (i.e. brown bagging, white bagging, etc.). Proposed legislative policies and regulatory reforms that impact Medicare payments may have a key role towards infusion services through changes in the payment structure. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Community health Workers play a role in improving health outcomes and public health by connecting patients with community resources. In this podcast episode, we discuss key takeaways from a research project evaluating the impact of interprofessional collaboration with community health workers on pharmacy students’ knowledge of social determinants of health. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

John Arnold, PhD, RPh , Director of Non-Degree Programs at Samford University and Matt Rewald, BS, CPhT, DPLA Assistant Professor of Pharmacy at the Mayo Clinic, join ASHP host Cindy von Heeringen, Senior Education Director on the National Meetings team to discuss their upcoming Midyear session, Empowering Tomorrow's Pharmacy Technicians: Fostering Partnerships with Academia to Develop Cutting-Edge Technician Training Programs. The speakers highlight a unique opportunity to augment technician training by partnering with schools of pharmacy and using the infrastructure and resources to potentially mitigate the technician shortage with another pathway for developing the profession. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast is part of a series unpacking harmful PBM practices. The series will inform listeners about PBMs’ influence over nearly all aspects of patient care and the profession of pharmacy. The series will also identify key resources and strategies enabling pharmacy professionals to engage in effective advocacy efforts to achieve meaningful PBM reform. In this episode, we look at how insurers leverage practices restricting acquisition and administration of infused medications to steer patients towards insurer-owned providers and explore how these policies impact pharmacists, patients, and overall quality of care. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

We all know what antimicrobial stewardship (AMS) is, but implementation in the community pharmacy space is something that is still developing. This podcast episode will empower listeners to recognize that there are small things that they can do to improve AMS in the community setting. The episode will also discuss how the Centers of Disease Control's core elements of outpatient AMS apply to practitioners in a community pharmacy setting. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join us for an insightful episode where experts Brian W. Gilbert, PharmD, MBA, BCCCP, FCCM, FNCS, Lance Ray, PharmD, BCEMP, BCPS, and Ruben D. Santiago, PharmD, BCCCP, BCPS discuss an upcoming educational session at the Midyear Clinical Meeting and Exhibition focused on the current state of illicit drug use in the United States. The session will cover both nonpharmacological and pharmacological management strategies, offering valuable insights for pharmacists via engaging case-based scenarios. Don’t miss this opportunity to stay informed on critical trends and treatment approaches! The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In anticipation of the 2024 ASHP Conference for Pharmacy Leaders, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP as she interviews Jared White, manager, pharmacy data analytics at UCSF and Ben Michaels, data science pharmacist at UCSF Medical Center at UCSF as they discuss their upcoming sessions AI for Pharmacy Leaders, Part 1 and Part 2. They will provide background information and forward-facing strategies expressly curated for leaders to stay abreast of this ever-changing landscape. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Part 2 of this podcast series discusses the background for current barcode formats used on medication packages. Our speakers provide insight into regulations currently affecting barcoding practices, as well as changes that are needed for the future. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join us for an insightful episode featuring an expert speaker, Megan Adelman, PharmD, BCGP, BCPS, CDCES from the upcoming Midyear Clinical Meeting and Exhibition. She will explore generational differences in the pharmacy workforce, offer strategies for precepting the newest generation, and highlight the unique skills and perspectives they bring to the field. Don’t miss this opportunity to learn how to foster collaboration across generations in your pharmacy practice! The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In anticipation of the 2024 ASHP Conference for Pharmacy Leaders, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP as she interviews Denise Scarpelli, vice president and chief pharmacy officer at University of Chicago to discuss the upcoming session, How Strong is Your Bench? Developing Future Pharmacy Leaders with Strategic Succession Planning. Denise will give an overview of the session design and share a bit of her own story with this creative process for developing future leaders. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join a conversation about unique education planned for a needed and sensitive topic at the upcoming conference for pharmacy leaders. Bill Kernan, a seasoned leader is joined by health system HR professional Adriana Ciltara as they give a preview of the program. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, the team from the Ohio State University Wexner Medical Center to discuss their award-winning submission to the ASHP Best Practices. They will share how their program demonstrated improvements in opioid utilization, reduction in medication errors and an increase in patient safety. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast examines issues surrounding current requirements for barcodes on unit-of-use medication packages and provides insight into the opportunities available for utilizing updated barcoding practices. Speakers discuss what is needed from vendors, federal agencies, and pharmacies to facilitate a change in current practices. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Dr. Zoe Karavolis and Dr. Antoine Douaihy discuss the AJHP Practice Research Report, “Pharmacist-implemented intervention to surmount COVID-19 vaccination hesitancy in adults with substance use disorders,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Pharmacy preceptors often face the emotional strain of balancing their clinical responsibilities with the need to provide meaningful, constructive feedback to their learners. In addition, they often struggle with navigating learners’ emotions while delivering constructive feedback, aiming to be supportive yet honest in a way that doesn’t discourage growth. Join us at the National Pharmacy Preceptors Conference on October 2-3 to learn more. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Harnessing the plethora of data is a critical success factor for hospital and health system executives and the sources of data are continually growing in complexity and reliability. This podcast will provide insights and instruction from two hospital and health system C-suite executives on examples and lessons learned on leveraging data to improve outcomes and decision making in a multi-hospital health system. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast is part of a series unpacking harmful PBM practices. The series will inform listeners about PBMs’ influence over nearly all aspects of patient care and the profession of pharmacy. The series will also identify key resources and strategies enabling pharmacy professionals to engage in effective advocacy efforts to achieve meaningful PBM reform. In this episode, we discuss how PBMs have co-opted specialty pharmacy practice to maximize their profits at the direct expense of patients, how policymakers can address these practices and how pharmacists can push back against these actions. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast will focus on how generative artificial intelligence (AI) impacts outpatient pharmacy practice. The speakers discuss how AI can help augment patient-centric and administrative functions to help pharmacists improve their outpatient practice, both presently and in the future. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This session, presented at the 2024 virtual National Pharmacy Preceptors Conference, will define the fundamentals of artificial intelligence (AI), apply AI utilization strategies to experiential learning, and discuss potential pitfalls and ethical challenges when using AI within pharmacy practice. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, listeners will hear from a pharmacy leader about the pioneering experience of her health system’s pharmacy drone delivery program. Discussion will include implications for the medication-use process, lessons learned, and future considerations for pharmacy drone deliveries. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

With the increase in high-cost medication utilization in the inpatient setting, pharmacy leaders need to develop a systematic approach to evaluating, procuring, and accounting for these medications in the drug budget. Hospitals may vary in the resources dedicated to performing these assessments. Please join us as we discuss strategies for managing high-cost medications with pharmacy leaders from across the continuum of hospital/health-system sizes. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The podcast explores the integration of gaming in pharmacy education, highlighting how interactive and immersive games can enhance student engagement and learning. Speakers discuss the benefits of gamified learning experiences in understanding pharmaceutical concepts and improving problem-solving skills in a dynamic educational environment. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

During this podcast, we will be discussing strategies to gain approval of potential new positions to an existing department or the creation of new clinic or service that would include pharmacy support. These positions are typically approved by the C-Suite of an organization. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Dr. Leah Webster and Dr. Corey Wachter discuss the AJHP Descriptive Report, “The vital role of clinical pharmacy services within the hospital at home interdisciplinary team,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

When your patient list seems insurmountable, how do you prioritize your patient care activities for the day? Join us to hear from pharmacy leaders in the informatics field who have experience with developing and implementing a scoring system within the electronic health record to triage patient care, identify intervention opportunities, and prioritize clinical pharmacy services. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The goal of this podcast is to help describe specific productivity, clinical and operational benchmarking metrics that are utilized in hospitals throughout the US. Listeners should walk away with a new understanding of meaningful metrics and how to develop them. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

With the advent of artificial intelligence, groundbreaking advancements are changing the landscape of drug diversion prevention. Advanced analytics are uncovering proactive strategies to prevent and address drug diversion more robustly. This transformative technology has reshaped the perception of drug diversion to one that requires a collaborative, interdisciplinary approach. In this podcast, we delve into the imperative for pharmacists, nurses, and other healthcare professionals to unite, taking collective responsibility for tackling this escalating challenge. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Dr. William Hammond and Patricia Valdez discuss the AJHP Descriptive Report, “Impact of a pharmacy technician on an interprofessional antithrombotic stewardship program at an academic medical center,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

With the increase in high-cost oncologic medications being utilized in the inpatient setting, pharmacy leaders need to develop a systematic approach to evaluating, procuring, and accounting for these medications in the departmental budget as well as ensuring optimal patient outcomes. Hospitals may vary widely in the resources dedicated to performing these assessments. Please join us in this series as we discuss strategies for managing high-cost oncologic medications with pharmacy leaders from two large academic medical centers. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast is the second in a 4-episode miniseries exploring the careers pharmacists can have in hospital pharmacy administration. In these episodes, pharmacy students will be interviewing a variety of professionals in different pharmacy admin fields and delving into how they got where they are and the intricacies of their jobs. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast details the role, training, and experience of three pharmacists who work in clinical research. The guests discuss clinical research pharmacy practice at institutional, industry, and federal levels and share advice for pharmacists and pharmacy students who want to start a career in clinical research. This podcast is hosted by Michaela L. Myerson, Pharm.D., who at the time of recording, is a PGY-2 Investigational Drugs and Research resident. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.